Celebrex and Supraventricular tachycardia - from FDA reports


Summary

Supraventricular tachycardia is found among people who take Celebrex, especially for people who are female, 60+ old , have been taking the drug for 2 - 5 years, also take medication Fosamax, and have Metastases to bone. This review analyzes which people have Supraventricular tachycardia with Celebrex. It is created by eHealthMe based on reports of 98,692 people who have side effects when taking Celebrex from FDA , and is updated regularly.

What to expect?

If you take Celebrex and have Supraventricular tachycardia, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Celebrex and have Supraventricular tachycardia

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Nov, 23, 2017

98,692 people reported to have side effects when taking Celebrex.
Among them, 92 people (0.09%) have Supraventricular tachycardia


Number of reports submitted per year:

Could Celebrex cause Supraventricular tachycardia?

Time on Celebrex when people have Supraventricular tachycardia *:

  • < 1 month: 7.14 %
  • 1 - 6 months: 28.57 %
  • 6 - 12 months: 7.14 %
  • 1 - 2 years: 7.14 %
  • 2 - 5 years: 28.57 %
  • 5 - 10 years: 21.43 %
  • 10+ years: 0.0 %

Gender of people who have Supraventricular tachycardia when taking Celebrex *:

  • female: 78.41 %
  • male: 21.59 %

Age of people who have Supraventricular tachycardia when taking Celebrex *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 1.47 %
  • 30-39: 0.0 %
  • 40-49: 13.24 %
  • 50-59: 19.12 %
  • 60+: 66.18 %

Top conditions involved for these people *:

  • Metastases To Bone (10 people, 10.87%)
  • Osteoporosis (9 people, 9.78%)
  • Multiple Myeloma (7 people, 7.61%)
  • High Blood Cholesterol (6 people, 6.52%)
  • Back Pain (4 people, 4.35%)

Top co-used drugs for these people *:

  • Fosamax (18 people, 19.57%)
  • Zometa (16 people, 17.39%)
  • Ambien (14 people, 15.22%)
  • Protonix (13 people, 14.13%)
  • Hydrochlorothiazide (13 people, 14.13%)

Top other side effects for these people *:

  • Breathing Difficulty (33 people, 35.87%)
  • Chest Pain (32 people, 34.78%)
  • High Blood Pressure (31 people, 33.70%)
  • Atrial Fibrillation/flutter (30 people, 32.61%)
  • Joint Pain (27 people, 29.35%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

Do you have Supraventricular tachycardia when taking Celebrex?

Expand the study to include all drugs with the same ingredients

Supraventricular tachycardia and drugs with ingredients of celecoxib.

Expand the study to include reports from both FDA and eHealthMe

Supraventricular tachycardia and Celebrex from FDA and eHealthMe reports

Celebrex

Celebrex has active ingredients of celecoxib. It is often used in arthritis. (latest outcomes from Celebrex 101,631 users)

Supraventricular tachycardia

Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node) has been reported by people with high blood pressure, osteoporosis, diabetes, depression, pain (latest reports from 10,733 Supraventricular tachycardia patients).

Browse all side effects of Celebrex

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Supraventricular tachycardia

Supraventricular tachycardia

Could your condition cause Supraventricular tachycardia

Supraventricular tachycardia

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Celebrex and have Supraventricular tachycardia.

Questions to the study

More questions >

User reviews to the study

More reviews >